Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. HeraMED Limited
  6. News
  7. Most relevant
    HMD   AU0000028367

HERAMED LIMITED

(HMD)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about HERAMED LIMITED
07/18HERAMED : Obstetrix Medical Signs Deal for Integration of Maternity Care Platfor..
MT
07/18HeraMED Limited Announces Change of Registered Office
CI
07/18HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
05/13HERAMED : Enters Pilot Deal With US Clinical Services Provider
MT
05/12HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
04/22HERAMED : Signs Deal with Joondalup Health Campus for HeraCARE Platform; Shares ..
MT
04/21HeraMED Limited Announces Signed an Agreement with Joondalup Health Campus
CI
02/25Heramed Limited Reports Earnings Results for the Full Year Ended December 31,..
CI
02/08HERAMED : Israeli Hospital to Begin Pilot Study of HeraMED's Maternity Device, S..
MT
02/07HeraMED Limited Announces Sheba Medical Centre, Initiates Pilot to Test Both ..
CI
02/04HERAMED : Raises Nearly $2 Million via Share Placement; Shares Rise 11%
MT
01/27HERAMED : Secures Two-Year Subscription Extension from Brazilian Healthcare Grou..
MT
01/26Hapvida Extends its subscription for HeraCARE SaaS and cloud monitoring servi..
CI
2020HeraMED Limited Announces Mayo Clinic approves Clinical Study of HeraBEATTM t..
CI
2020HERAMED : Partners With Teleperinatal to Deploy HerCARE and HeraBEAT; Shares Up ..
MT
2020HeraMED Limited Signs Letter of Intent with Teleperinatal
CI
202019,022,000 Options of HeraMED Limited are subject to a Lock-Up Agreement Endi..
CI
2020927,504 Options of HeraMED Limited are subject to a Lock-Up Agreement Ending ..
CI
202035,067,847 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreem..
CI
20208,277,494 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreeme..
CI
20202,743,655 Options of HeraMED Limited are subject to a Lock-Up Agreement Endin..
CI
2020HERAMED : Integrates Technology with US Virtual Care Platform; Shares Fall 4%
MT
2020HeraMED Limited Announces Partnership with eCare21, Inc & Functional Integrat..
CI
2020Heramed Limited Announces Outstanding Clinical Study Results
CI
2020HeraMED Limited Partnership with Leading Virtual Care Platform eCare21 in US
CI
2020HeraMED Limited Announces Enrolment in Clinical Study at Joondalup Health Cam..
CI
2020Heramed Limited Reports Earnings Results for the Half Year Ended June 30, 202..
CI
2020HeraMED Limited Announces the Clinical Study at the Joondalup Health Campus i..
CI
2020HeraMED Limited Extends its Collaboration with Mayo Clinic
CI
2020HeraMED Limited announced that it expects to receive CAD 0.082999 million in ..
CI
2020Heramed Limited Receives Final Approvals to Commence Clinical Study at Joonda..
CI
2020HeraMED Limited Announces Agreement with Freeman Rd & PHI Group to Arrange an..
CI
2020HeraMED Limited Signs Exclusive Distribution Agreement with Advanced Pregnanc..
CI
2020HeraMED Limited Provides Product Development Update
CI
2020HeraMED Limited Announces Change of Company Secretary; Announces Changes Regi..
CI
2020Heramed Limited Reports Earnings Results for the Full Year Ended December 31,..
CI
2020HeraMED Limited Clinical Trial Study Details with the Mayo Clinic
CI
2020HeraMED Appoints Alexander Radke as General Manager of US Operations
CI
2019HeraMED Limited announced that it has received AUD 1.423532 million in fundin..
CI
2019HeraMED Limited announced that it expects to receive AUD 1.423532 million in ..
CI
20198,277,494 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreeme..
CI
20192,743,655 Options of HeraMED Limited are subject to a Lock-Up Agreement Endin..
CI
20194,578,000 Options of HeraMED Limited are subject to a Lock-Up Agreement Endin..
CI
2019HeraMED Limited Announces Partnership with Cloudnine Hospital Group
CI
2019HeraMED Limited, Kinderheldin GmbH (Kinderheldin) and Duttenhofer Group Enter..
CI
2019HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device
CI
2019HeraMED Limited Provides Update on the Trial of its HeraBEAT and HeraCARE Pro..
CI
2019HeraMED Limited Enters Collaboration Agreement with IntMED Software Ltd ME
CI
2019HeraMED Limited and Mayo Clinic to Co-Develop a New Platform
CI
2019HeraMED Limited Provide an Update on the Trial of Smart Medical Grade Foetal ..
CI
2019Federal National Mortgage Association Guaranteed Mortgage Pass Thru Certifica..
CI
2019HeraMED Limited Secures Initial Order for €30,000 with Duttenhofer Group
CI
2019HeraMED Limited Announces HeraCARE PRO successfully integrated into Hapvida's..
CI
2019Heramed Limited Launches Its Medical Grade Foetal Heart Rate Monitor, HeraBEA..
CI
201921,000 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreement ..
CI
201930,000 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreement ..
CI
2019444,000 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreement..
CI
20192,130,000 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreeme..
CI
2019808,500 Ordinary Shares of HeraMED Limited are subject to a Lock-Up Agreement..
CI
2019HeraMED Limited Appoints Paul A. Friedman to Company's Advisory Board
CI
2019HeraMED Limited Secures Binding Memorandum of Understanding with IBL Holding ..
CI
2019HeraMED Limited Enters into MoU with Medizane Inc
CI
2019HeraMED Limited Submits 510K Application to the US Food and Drug Administrati..
CI
2019HeraMED Limited Announces It Has Enters into A Partnership with Australian Cr..
CI
2019HeraMED Limited Launches HeraBEAT in the United Kingdom
CI
2019HeraMED Limited Announces Consolidated Earnings Results for the Year Ended De..
CI
2019HeraMED Limited Appoints Arturo Weschler MD, as VP of Innovation
CI
2019HeraMED Limited Secures Manufacturing Agreement with Quasar
CI
2019Heramed Limited Announces Unaudited Earnings Results for the Year Ended Decem..
CI
2019HeraMED Limited Signs Comprehensive Distribution Agreement with Dale Group In..
CI
2018HeraMED Limited Appoints Doron Birger as Director
CI
2018HeraMED Limited Appoints Ronald Weinberger as Director
CI
2018HeraMED Limited Appoints Tal Slonim as Director
CI
2018HeraMED Limited Appoints David Groberman as Director
CI
2018HeraMED Limited Appoints David Hinton as Director
CI
1  2Next
Upcoming event on HERAMED LIMITED